Favorable versus detrimental cardiovascular responses to intermittent hypoxia conditioning (IHC) are heavily dependent on experimental or pathological conditions, including the duration, frequency and intensity of the hypoxia exposures. Recently, we demonstrated that a program of moderate, normobaric IHC (FIO2 9.5–10% for 5–10 min/cycle, with intervening 4 min normoxia, 5–8 cycles/day for 20 days) in dogs afforded robust cardioprotection against infarction and arrhythmias induced by coronary artery occlusion–reperfusion, but this protection has not been verified in other species. Accordingly, in this investigation cardio- as well as vasoprotection were examined in male Wistar rats completing the normobaric IHC program or a sham program in which the rats continuously breathed atmospheric air. Myocardial ischemia and reperfusion (IR) was imposed by occlusion and reperfusion of the left anterior descending coronary artery in in situ experiments and by subjecting isolated, perfused hearts to global ischemia–reperfusion. Cardiac arrhythmias and myocardial infarct size were quantified in in situ experiments. Endothelial function was evaluated from the relaxation to acetylcholine of norepinephrine-precontracted aortic rings taken from in situ IR experiments, and from the increase in coronary flow produced by acetylcholine in isolated hearts. IHC sharply reduced cardiac arrhythmias during ischemia and decreased infarct size by 43% following IR. Endothelial dysfunction in aorta was marked after IR in sham rats, but not significant in IHC rats. Similar findings were found for the coronary circulations of isolated hearts. These findings support the hypothesis that moderate, normobaric IHC is cardio- and vasoprotective in a rat model of IR.
ParishJMSomersVK. Obstructive sleep apnea and cardiovascular disease. Mayo Clin Proc2004; 79: 1036–46.
2.
ThomasBJWanstallJC. Alterations in pulmonary vascular function in rats exposed to intermittent hypoxia. Eur J Pharmacol2003; 477: 153–61.
3.
PhillipsSAOlsonEBMorganBJLombardJH. Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol2004; 286: H388–93.
4.
DoppJMPhilippiNRMarcusNJOlsonEBBirdCEMoranJJMuellerSWMorganBJ. Xanthine oxidase inhibition attenuates endothelial dysfunction caused by chronic intermittent hypoxia in rats. Respiration2011; 82: 458–67.
5.
GuoQHTianYLWangZLiAYMaZHGuoYJWeissJWJiESChuL. Endothelin receptors in augmented vasoconstrictor responses to endothelin-1 in chronic intermittent hypoxia. Clin Exp Pharmacol Physiol2013; 40: 449–57.
6.
Joyeux-FaureMStanke-LabesqueFLefebvreBBéguinPGodin-RibuotCLaunoisSHBessardGLévyP. Chronic intermittent hypoxia increases infarction in the isolated rat heart. J Appl Physiol2005; 98: 1691–6.
7.
MeersonFZGomzakovOAShimkovichMV. Adaptation to high altitude hypoxia as a factor preventing development of myocardial ischemic necrosis. Am J Cardiol1973; 31: 30–4.
8.
MeersonFZUstinovaEEOrlovaEH. Prevention and elimination of heart arrhythmias by adaptation to intermittent high altitude hypoxia. Clin Cardiol1987; 10: 783–9.
9.
XieYZhuWZZhuYChenLZhouZNYangHT. Intermittent high altitude hypoxia protects the heart against lethal Ca2+ overload injury. Life Sci2004; 76: 559–72.
10.
ZongPSettySSunWMartinezRTuneJDEhrenburgIVTkatchoukENMalletRTDowneyHF. Intermittent hypoxic training protects canine myocardium from infarction. Exp Biol Med2004; 229: 806–12.
11.
ChenLLuXYLiJFuJDZhouZNYangHT. Intermittent hypoxia protects cardiomyocytes against ischemia-reperfusion injury-induced alterations in Ca2+ homeostasis and contraction via the sarcoplasmic reticulum and Na+/Ca2+ exchange mechanisms. Am J Physiol Cell Physiol2006; 290: C1221–9.
12.
MalletRTRyouMGWilliamsAGJrHowardLDowneyHF. β1-Adrenergic receptor antagonism abrogates cardioprotective effects of intermittent hypoxia. Basic Res Cardiol2006; 101: 436–46.
13.
KolárFJezkováJBalkováPBrehJNeckárJNovákFNovákováOTomásováHSrbováMOst'ádalBWilhelmJHergetJ. Role of oxidative stress in PKC-delta upregulation and cardioprotection induced by chronic intermittent hypoxia. Am J Physiol Heart Circ Physiol2007; 292: H224–30.
14.
KolarFNekarJOstadalBMaslovLNStakheevDLTayurskayaASLishmanovYB. Role of ATP-sensitive K+-channels in antiarrhythmic and cardioprotective action of adaptation to intermittent hypobaric hypoxia. Bull Exp Biol Med2008; 145: 418–21.
15.
GuoHCZhangZZhangLNXiongCFengCLiuQLiuXShiXLWangYL. Chronic intermittent hypobaric hypoxia protects the heart against ischemia/reperfusion injury through upregulation of antioxidant enzymes in adult guinea pigs. Acta Pharmacol Sin2009; 30: 947–55.
16.
BeguinPCJoyeux-FaureMGodin-RibuotDLevyPRibuotC. Acute intermittent hypoxia improves rat myocardium tolerance to ischemia. J Appl Physiol2005; 99: 1064–9.
17.
CaiXLWuLYuZLiuJLZhouZNLiuJYangHT. Mitochondrial energy metabolism plays a critical role in the cardioprotection afforded by intermittent hypobaric hypoxia. Exp Physiol2012; 97: 1105–18.
18.
BalkováPHlaváčkováMMilerováMNeckářJKolářFNovákFNovákováO. N-acetylcysteine treatment prevents the up-regulation of MnSOD in chronically hypoxic rat hearts. Physiol Res2011; 60: 467–74.
19.
WangZHChenYXZhangCMWuLYuZCaiXLGuanYZhouZNYangHT. Intermittent hypobaric hypoxia improves postischemic recovery of myocardial contractile function via redox signalling during early reperfusion. Am J Physiol Heart Circ Physiol2011; 301: H1695–705.
20.
XuWQYuZXieYHuangGQShuXHZhuYZhouZNYangHT. Therapeutic effect of intermittent hypobaric hypoxia on myocardial infarction in rats. Basic Res Cardiol2011; 106: 329–42.
21.
ZhouJJWeiYZhangLZhangJGuoLYGaoCLiDPZhangY. Chronic intermittent hypobaric hypoxia prevents cardiac dysfunction through enhancing antioxidation in fructose-fed rats. Can J Physiol Pharmacol2013; 91: 332–7.
22.
BehmRHonigAGrietheMSchmidtMSchneiderP. Sustained suppression of voluntary sodium intake of spontaneously hypertensive rats (SHR) in hypobaric hypoxia. Biomed Biochem Acta1984; 43: 975–85.
23.
PotievskaiaVIChizhov AIa. Effect of intermittent normobaric hypoxia on dynamics of disease state in patients with hypertension. Fiziol Zh1992; 38: 53–7.
24.
SimonenkoVBErmolaevALPoshievskaiaVIStepaniantsOS. Effects of adaptation to intermittent normobaric hypoxia on the results of 24-hour monitoring of arterial pressure in hypertensive patients. Klin Med2003; 81: 22–5.
25.
MeersonFZ. Essentials of adaptive medicine: protective effects of adaptation, Moscow: Hypoxia Medical Ltd, 1994.
26.
SerebrovskayaTVManukhinaEBSmithMLDowneyHFMalletRT. Intermittent hypoxia: cause of or therapy for systemic hypertension?Exp Biol Med2008; 233: 627–50.
27.
LyaminaNPLyaminaSVSenchikninVNMalletRTDowneyHFManukhinaEB. Normobaric hypoxia conditioning reduces blood pressure and normalizes nitric oxide synthesis in patients with arterial hypertension. J Hypertens2011; 29: 2265–72.
MashinaSYAleksandrinVVGoryachevaAVVlasovaMAVaninAFMalyshevIYManukhinaEB. Adaptation to hypoxia prevents disturbances of cerebral blood flow during neurodegeneration. Bull Exp Biol Med2006; 142: 169–72.
30.
JungMESimpkinsJWWilsonAMDowneyHFMalletRT. Intermittent hypoxia conditioning prevents behavioral deficit and brain oxidative stress in ethanol-withdrawn rats. J Appl Physiol2008; 105: 510–7.
31.
ManukhinaEBGoryachevaAVBarskovIVViktorovIVGusevaAAPshennikovaMGKhomenkoIPMashinaSYPokidyshevDAMalyshevIY. Prevention of neurodegenerative damage to the brain in rats in experimental Alzheimer's disease by adaptation to hypoxia. Neurosci Behav Physiol2010; 40: 737–43.
32.
GoryachevaAVKruglovSVPshennikovaMGSmirinBVMalyshevIYBarskovIVViktorovIVDowneyHFManukhinaEB. Adaptation to intermittent hypoxia restricts nitric oxide overproduction and prevents beta-amyloid toxicity in rat brain. Nitric Oxide2010; 23: 289–99.
33.
StoweAMAltayTFreieABGiddayJM. Repetitive hypoxia extends endogenous neurovascular protection for stroke. Ann Neurol2011; 69: 975–85.
34.
JuXMalletRTDowneyHFMetzgerDBJungME. Intermittent hypoxia conditioning protects mitochondrial cytochrome c oxidase of rat cerebellum from ethanol withdrawal stress. J Appl Physiol2012; 112: 1706–14.
35.
NeubauerJA. Physiological and pathophysiological responses to intermittent hypoxia. J Appl Physiol2001; 90: 1593–9.
36.
LukyanovaLDGermanovaELKopaladzeRA. Development of resistance of an organism under various conditions of hypoxic preconditioning: role of the hypoxic period and reoxygenation. Bull Exp Biol Med2009; 147: 400–4.
37.
Amiiants VIu. The characteristics of the adaptation to the hypoxic conditions at a low-altitude health resort in IHD patients after an aortocoronary bypass. Ter Arkh1996; 68: 52–4.
38.
AleshinIATin'kovANKots IaITverdokhlibVP. Experience in treating patients with cardiovascular diseases by means of adaptation to periodic barochamber hypoxia. Ter Arkh1997; 69: 54–8.
39.
EhrenbourgIVGorbachenkovAA. Interval hypoxic training in ischemic heat disease. Hypox Med J1993; 1: 13–6..
40.
LyaminaNPPilyavskyBG. Interval hypoxic training for the treatment of cardiac rhythm disorders in patients with neurocirculatory dystonia. Hypox Med J1995; 1: 18–20.
41.
BernardiLPassinoCSerebrovskayaZSerebrovskayaTAppenzellerO. Respiratory and cardiovascular adaptations to progressive hypoxia; effect of interval hypoxic training. Eur Heart J2001; 22: 879–86.
42.
BernardiL. Interval hypoxic training. Adv Exp Med Biol2001; 502: 377–99.
43.
BurtscherMPachingerOEhrenbourgIMitterbauerGFaulhaberMPuhringerRTkatchoukE. Intermittent hypoxia increases exercise tolerance in elderly men with and without coronary artery disease. Int J Cardiol2004; 96: 247–54.
44.
BurtscherMHaiderTDomejWLinserTGattererHFaulhaberMPoceccoEEhrenburgITkatchukEKochRBernardiL. Intermittent hypoxia increases exercise tolerance in patients at risk for or with mild COPD. Respir Physiol Neurobiol2009; 165: 97–103.
45.
Vorob'evLPChizhov AIaPotievskaiaVI. The possibilities of using intermittent normobaric hypoxia for treating hypertension patients. Ter Arkh1994; 66: 12–5.
46.
MurryCEJenningsRBReimerKA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation1986; 74: 1124–36.
47.
ManukhinaEBMashina SIuSmirinBVLyaminaNPSenchikhinVNVaninAFMalyshevIY. Role of nitric oxide in adaptation to hypoxia and adaptive defense. Physiol Res2000; 49: 89–97.
48.
JabsAFasolaFMuxelSMünzelTGoriT. Ischemic and non-ischemic preconditioning: endothelium-focused translation into clinical practice. Clin Hemorheol Microcirc2010; 45: 185–91.
49.
SealJBGewertzBL. Vascular dysfunction in ischemia-reperfusion injury. Ann Vasc Surg2005; 19: 572–84.
50.
SouzaDGCassaliGDPooleSTeixeiraMM. Effects of inhibition of PDE4 and TNF-α on local and remote injuries following ischaemia and reperfusion injury. Br J Pharmacol2001; 134: 985–94.
51.
ZhaoMHeXWierWGZhangHLZhaoMYuXJZangWJ. Endothelial dysfunction in rat mesenteric artery after regional cardiac ischaemia-reperfusion. Exp Physiol2012; 97: 70–9.
52.
BouchardRABoseD. Analysis of the interval-force relationship in rat and canine ventricular myocardium. Am J Physiol Heart Circ Physiol1989; 257: H2036–47.
53.
LiuYThorntonJDCohenMVDowneyJMSchafferSW. Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction. Circulation1993; 88: 1273–8.
54.
TribulovaNRavingerovaTSlezakJ. Reperfusion-induced arrhythmias in isolated rat heart: an index of cellular damage or viability of cardiomyocytes?J Basic Clin Physiol Pharmacol1993; 4: 321–34.
55.
YuYTuneJDDowneyHF. Elevated right atrial pressure does not reduce collateral blood flow to ischemic myocardium. Am J Physiol Heart Circ Physiol1997; 273: H2296–303.
56.
BorgerDREssigDA. Induction of HSP 32 gene in hypoxic cardiomyocytes is attenuated by treatment with N-acetyl-L-cysteine. Am J Physiol Heart Circ Physiol1998; 274: H965–73.
57.
YuanFLiHWSongSJTengXMaHJGuoZZhangYZhouZN. Opioid receptors mediate enhancement of Ach-induced aorta relaxation by chronic intermittent hypobaric hypoxia. Sheng Li Xue Bao2013; 65: 269–75.
58.
ManukhinaEBDowneyHFMalletRT. Role of nitric oxide in cardiovascular adaptation to intermittent hypoxia. Exp Biol Med2006; 231: 343–65.
59.
PrysiazhnaODKotsiurubaAVTalanovSOSahachVF. Normalizing effect of intermittent hypoxic training on the function of endothelium in experimental diabetes mellitus. Fiziol Zh2007; 53: 3–7. [Ukr].
MalletRTRyouMGManukhinaEBDowneyHFβ-Adrenergic signaling and ROS: pivotal roles in intermittent, normobaric hypoxia-induced cardioprotection. In: XiLSerebrovskayaTV (eds). Intermittent hypoxia: from molecular mechanisms to clinical applications, New York, NY: Nova Science Publishers, 2009, pp. 151–74.
62.
RyouMGSunJOguayoKNManukhinaEBDowneyHFMalletRT. Hypoxic conditioning suppresses nitric oxide production upon myocardial reperfusion. Exp Biol Med2008; 233: 766–74.
63.
AndreadouIIliodromitisEKFarmakisDKremastinosDT. To prevent, protect and save the ischemic heart: antioxidants revisited. Expert Opin Ther Targets2009; 13: 945–56.
64.
ManukhinaEBTerekhinaOLBelkinaLMAbramochkinDVDowneyHF. Adaptation to hypoxia prevents endothelial dysfunction of coronary and non-coronary blood vessels during myocardial ischemia and reperfusion injury. FASEB J2013; 27: 1207.13–1207.13. (abstract).
65.
MarcusNJPhilippiNRBirdCELiYLSchultzHDMorganBJ. Effect of AT1 receptor blockade on intermittent hypoxia-induced endothelial dysfunction. Respir Physiol Neurobiol2012; 183: 67–74.
66.
WangBYanBSongDYeXLiuSF. Chronic intermittent hypoxia down-regulates endothelial nitric oxide synthase expression by an NF-κB-dependent mechanism. Sleep Med2013; 14: 165–71.
67.
BertugliaS. Intermittent hypoxia modulates nitric oxide-dependent vasodilation and capillary perfusion during ischemia-reperfusion-induced damage. Am J Physiol Heart Circ Physiol2008; 294: H1914–22.
68.
LaursenBEDamMYMulvanyMJSimonsenU. Hypoxia-induced pulmonary vascular remodelling and right ventricular hypertrophy is unaltered by long-term oral L-arginine administration. Vascul Pharmacol2006; 49: 71–6.
69.
ZunguMYoungMEStanleyWCEssopMF. Expression of mitochondrial regulatory genes parallels respiratory capacity and contractile function in a rat model of hypoxia-induced right ventricular hypertrophy. Mol Cell Biochem2008; 318: 175–81.
70.
PanPZhangXQianHShiWWangJBoYLiW. Effects of electro-acupuncture on endothelium-derived endothelin-1 and endothelial nitric oxide synthase of rats with hypoxia-induced pulmonary hypertension. Exp Biol Med2010; 235: 642–8.
71.
OstádalBResslJUrbanováDProcházkaJPelouchVWidimskyJ. Effect of verapamil on pulmonary hypertension and right ventricular hypertrophy indiced in rats by intermittent high altitude hypoxia. Respiration1981; 42: 221–7.
72.
KalariaRNSpoorsLLaudeEAEmeryCJThwaites-BeeDFairlieJOakleyAEBarerDHBarerGR. Hypoxia of sleep apnoea: cardiopulmonary and cerebral changes after intermittent hypoxia in rats. Respir Physiol Neurobiol2004; 140: 53–62.
